Table 1.
Characteristics of breast cancer patients according to use and nonuse of Chinese herb.
| Variable | Breast cancer patients | p value | |||
|---|---|---|---|---|---|
| Chinese herb used | |||||
| No (N = 6928) | Yes (N = 6928) | ||||
| n | % | n | % | ||
| Age group | 0.99 | ||||
| 18–39 | 1056 | 15.24 | 1056 | 15.24 | |
| 40–59 | 5377 | 77.61 | 5377 | 77.61 | |
| ≥60 | 495 | 7.14 | 495 | 7.14 | |
| Mean ± SD (years)a | 49.59 (9.73) | 49.56 (9.73) | 0.8371 | ||
| Baseline CCI score | 0.99 | ||||
| 0 | 6491 | 93.69 | 6491 | 93.69 | |
| 1 | 227 | 3.28 | 227 | 3.28 | |
| ≥2 | 210 | 3.03 | 210 | 3.03 | |
| Treatment | |||||
| Radiotherapy | 0.99 | ||||
| No | 3137 | 45.28 | 3137 | 45.28 | |
| Yes | 3791 | 54.72 | 3791 | 54.72 | |
| Chemotherapy | 0.99 | ||||
| No | 1291 | 18.63 | 1291 | 18.63 | |
| Yes | 5637 | 81.37 | 5637 | 81.37 | |
| Drug used | |||||
| Fluorouracil | 1275 | 18.4 | 2166 | 31.26 | <0.0001 |
| Gemcitabine | 353 | 5.1 | 562 | 8.11 | <0.0001 |
| Capecitabine | 601 | 8.67 | 804 | 11.61 | <0.0001 |
| Cyclophosphamide | 1336 | 19.28 | 2466 | 35.59 | <0.0001 |
| Tamoxifen | 3105 | 44.82 | 3842 | 55.46 | <0.0001 |
| Letrozole | 855 | 12.34 | 1155 | 16.67 | <0.0001 |
| Trastuzumab | 483 | 6.97 | 594 | 8.57 | 0.0004 |
| Follow time (mean, median) | 2.73 (1.94) | 4.32 (3.55) | |||
Chi-square test;a t-test.